Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies
The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of food effects on oral bioavailability. In this study, intragastric pH and pressure profiles present after the ingestion of the high-caloric, high...
Saved in:
Published in | Journal of controlled release Vol. 220; no. Pt A; pp. 71 - 78 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
28.12.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0168-3659 1873-4995 1873-4995 |
DOI | 10.1016/j.jconrel.2015.10.022 |
Cover
Abstract | The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of food effects on oral bioavailability. In this study, intragastric pH and pressure profiles present after the ingestion of the high-caloric, high-fat (964kcal) FDA standard breakfast were investigated in 19 healthy human subjects by using the telemetric SmartPill® capsule system (26×13mm). Since the gastric emptying of such large non-digestible objects is typically accomplished by the migrating motor complex phase III activity, the time required for recurrence of fasted state motility determined the gastric emptying time (GET). Following the diet recommendations of the FDA guidance on food effect studies, the mean GET of the telemetric motility capsule was 15.3±4.7h. Thus, the high caloric value of the standard breakfast impeded gastric emptying before lunch in 18 out of 19 subjects. During its gastric transit, the capsule was exposed to highly dynamic conditions in terms of pH and pressure, which were mainly dependent on further meal and liquid intake, as well as the intragastric capsule deposition behavior. Maximum pH values in the stomach were measured immediately after capsule intake. The median pH value of the 5min period after capsule ingestion ranged between pH3.3 and 5.3. Subsequently, the pH decreased relatively constantly and reached minimum values of pH0–1 after approximately 4h. The maximum pressure within the stomach amounted to 293±109mbar and was clearly higher than the maximum pressure measured at the ileocaecal junction (60±35mbar). The physiological data on the intraluminal conditions within the fed stomach generated in this study will hopefully contribute to a better understanding of food effects on oral drug product performance.
[Display omitted] |
---|---|
AbstractList | The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of food effects on oral bioavailability. In this study, intragastric pH and pressure profiles present after the ingestion of the high-caloric, high-fat (964kcal) FDA standard breakfast were investigated in 19 healthy human subjects by using the telemetric SmartPill® capsule system (26×13mm). Since the gastric emptying of such large non-digestible objects is typically accomplished by the migrating motor complex phase III activity, the time required for recurrence of fasted state motility determined the gastric emptying time (GET). Following the diet recommendations of the FDA guidance on food effect studies, the mean GET of the telemetric motility capsule was 15.3±4.7h. Thus, the high caloric value of the standard breakfast impeded gastric emptying before lunch in 18 out of 19 subjects. During its gastric transit, the capsule was exposed to highly dynamic conditions in terms of pH and pressure, which were mainly dependent on further meal and liquid intake, as well as the intragastric capsule deposition behavior. Maximum pH values in the stomach were measured immediately after capsule intake. The median pH value of the 5min period after capsule ingestion ranged between pH3.3 and 5.3. Subsequently, the pH decreased relatively constantly and reached minimum values of pH0–1 after approximately 4h. The maximum pressure within the stomach amounted to 293±109mbar and was clearly higher than the maximum pressure measured at the ileocaecal junction (60±35mbar). The physiological data on the intraluminal conditions within the fed stomach generated in this study will hopefully contribute to a better understanding of food effects on oral drug product performance.
[Display omitted] The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of food effects on oral bioavailability. In this study, intragastric pH and pressure profiles present after the ingestion of the high-caloric, high-fat (964kcal) FDA standard breakfast were investigated in 19 healthy human subjects by using the telemetric SmartPill® capsule system (26×13mm). Since the gastric emptying of such large non-digestible objects is typically accomplished by the migrating motor complex phase III activity, the time required for recurrence of fasted state motility determined the gastric emptying time (GET). Following the diet recommendations of the FDA guidance on food effect studies, the mean GET of the telemetric motility capsule was 15.3±4.7h. Thus, the high caloric value of the standard breakfast impeded gastric emptying before lunch in 18 out of 19 subjects. During its gastric transit, the capsule was exposed to highly dynamic conditions in terms of pH and pressure, which were mainly dependent on further meal and liquid intake, as well as the intragastric capsule deposition behavior. Maximum pH values in the stomach were measured immediately after capsule intake. The median pH value of the 5min period after capsule ingestion ranged between pH3.3 and 5.3. Subsequently, the pH decreased relatively constantly and reached minimum values of pH0–1 after approximately 4h. The maximum pressure within the stomach amounted to 293±109mbar and was clearly higher than the maximum pressure measured at the ileocaecal junction (60±35mbar). The physiological data on the intraluminal conditions within the fed stomach generated in this study will hopefully contribute to a better understanding of food effects on oral drug product performance. The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of food effects on oral bioavailability. In this study, intragastric pH and pressure profiles present after the ingestion of the high-caloric, high-fat (964 kcal) FDA standard breakfast were investigated in 19 healthy human subjects by using the telemetric SmartPill® capsule system (26 × 13 mm). Since the gastric emptying of such large non-digestible objects is typically accomplished by the migrating motor complex phase III activity, the time required for recurrence of fasted state motility determined the gastric emptying time (GET). Following the diet recommendations of the FDA guidance on food effect studies, the mean GET of the telemetric motility capsule was 15.3 ± 4.7 h. Thus, the high caloric value of the standard breakfast impeded gastric emptying before lunch in 18 out of 19 subjects. During its gastric transit, the capsule was exposed to highly dynamic conditions in terms of pH and pressure, which were mainly dependent on further meal and liquid intake, as well as the intragastric capsule deposition behavior. Maximum pH values in the stomach were measured immediately after capsule intake. The median pH value of the 5 min period after capsule ingestion ranged between pH 3.3 and 5.3. Subsequently, the pH decreased relatively constantly and reached minimum values of pH 0-1 after approximately 4 h. The maximum pressure within the stomach amounted to 293 ± 109 mbar and was clearly higher than the maximum pressure measured at the ileocaecal junction (60 ± 35 mbar). The physiological data on the intraluminal conditions within the fed stomach generated in this study will hopefully contribute to a better understanding of food effects on oral drug product performance. The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of food effects on oral bioavailability. In this study, intragastric pH and pressure profiles present after the ingestion of the high-caloric, high-fat (964 kcal) FDA standard breakfast were investigated in 19 healthy human subjects by using the telemetric SmartPill® capsule system (26 × 13 mm). Since the gastric emptying of such large non-digestible objects is typically accomplished by the migrating motor complex phase III activity, the time required for recurrence of fasted state motility determined the gastric emptying time (GET). Following the diet recommendations of the FDA guidance on food effect studies, the mean GET of the telemetric motility capsule was 15.3 ± 4.7 h. Thus, the high caloric value of the standard breakfast impeded gastric emptying before lunch in 18 out of 19 subjects. During its gastric transit, the capsule was exposed to highly dynamic conditions in terms of pH and pressure, which were mainly dependent on further meal and liquid intake, as well as the intragastric capsule deposition behavior. Maximum pH values in the stomach were measured immediately after capsule intake. The median pH value of the 5 min period after capsule ingestion ranged between pH 3.3 and 5.3. Subsequently, the pH decreased relatively constantly and reached minimum values of pH 0-1 after approximately 4 h. The maximum pressure within the stomach amounted to 293 ± 109 mbar and was clearly higher than the maximum pressure measured at the ileocaecal junction (60 ± 35 mbar). The physiological data on the intraluminal conditions within the fed stomach generated in this study will hopefully contribute to a better understanding of food effects on oral drug product performance.The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of food effects on oral bioavailability. In this study, intragastric pH and pressure profiles present after the ingestion of the high-caloric, high-fat (964 kcal) FDA standard breakfast were investigated in 19 healthy human subjects by using the telemetric SmartPill® capsule system (26 × 13 mm). Since the gastric emptying of such large non-digestible objects is typically accomplished by the migrating motor complex phase III activity, the time required for recurrence of fasted state motility determined the gastric emptying time (GET). Following the diet recommendations of the FDA guidance on food effect studies, the mean GET of the telemetric motility capsule was 15.3 ± 4.7 h. Thus, the high caloric value of the standard breakfast impeded gastric emptying before lunch in 18 out of 19 subjects. During its gastric transit, the capsule was exposed to highly dynamic conditions in terms of pH and pressure, which were mainly dependent on further meal and liquid intake, as well as the intragastric capsule deposition behavior. Maximum pH values in the stomach were measured immediately after capsule intake. The median pH value of the 5 min period after capsule ingestion ranged between pH 3.3 and 5.3. Subsequently, the pH decreased relatively constantly and reached minimum values of pH 0-1 after approximately 4 h. The maximum pressure within the stomach amounted to 293 ± 109 mbar and was clearly higher than the maximum pressure measured at the ileocaecal junction (60 ± 35 mbar). The physiological data on the intraluminal conditions within the fed stomach generated in this study will hopefully contribute to a better understanding of food effects on oral drug product performance. |
Author | Koziolek, M. Grimm, M. Seekamp, A. Schneider, F. Modeβ, Chr Roustom, T. Siegmund, W. Weitschies, W. |
Author_xml | – sequence: 1 givenname: M. surname: Koziolek fullname: Koziolek, M. organization: Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany – sequence: 2 givenname: F. surname: Schneider fullname: Schneider, F. organization: Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany – sequence: 3 givenname: M. surname: Grimm fullname: Grimm, M. organization: Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany – sequence: 4 givenname: Chr surname: Modeβ fullname: Modeβ, Chr organization: Department of Clinical Pharmacology, Center of Drug Absorption and Transport, University Medicine Greifswald, Greifswald, Germany – sequence: 5 givenname: A. surname: Seekamp fullname: Seekamp, A. organization: Department of Clinical Pharmacology, Center of Drug Absorption and Transport, University Medicine Greifswald, Greifswald, Germany – sequence: 6 givenname: T. surname: Roustom fullname: Roustom, T. organization: Department of Clinical Pharmacology, Center of Drug Absorption and Transport, University Medicine Greifswald, Greifswald, Germany – sequence: 7 givenname: W. surname: Siegmund fullname: Siegmund, W. organization: Department of Clinical Pharmacology, Center of Drug Absorption and Transport, University Medicine Greifswald, Greifswald, Germany – sequence: 8 givenname: W. surname: Weitschies fullname: Weitschies, W. email: werner.weitschies@uni-greifswald.de organization: Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26476174$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFuGyEQhlGVKnHSPEIrjj1kXWAX8KqHKoraJlKkXtozYmGIcdeLy7CR-vbBsnPJxQcEM_q_GeafS3I2pQkI-cjZkjOuvmyWG5emDONSMC5rbsmEeEcWfKXbput7eUYWVbdqWiX7C3KJuGGMybbT5-RCqE4rrrsFmR-mku2TxZKjo7t7aidPdxkQ5wz1kUIcAakNBTKNU7F_gaZAyxroOj6tG2fHVMmbQxRsoVuwI7VIZwRPQ8r1JE8hBHCFYpl9BPxA3gc7Ilwf7yvy58f333f3zeOvnw93t4-Nk4yXxrXQaqm008q3ygvwTgU_uEGKgYvAOjuEwAbnYYCOr1grvOasNqrju74yV-TzoW4d5N8MWMw2ooNxtBOkGU21jgmuV0qflHItOe872bEq_XSUzsMWvNnluLX5v3l1tQq-HgQuJ8QMwbhYbIlp73UcDWdmv0OzMccd7j8i9-m6w0rLN_Rrg1PctwMH1dHnCNmgizA58DFX741P8USFF17tul0 |
CitedBy_id | crossref_primary_10_1016_j_ijpharm_2021_120704 crossref_primary_10_1039_D4FO04447A crossref_primary_10_3390_ani12213022 crossref_primary_10_1007_s12247_018_9317_1 crossref_primary_10_1038_s41598_018_30937_1 crossref_primary_10_1021_acs_molpharmaceut_2c00782 crossref_primary_10_1080_17425247_2020_1750593 crossref_primary_10_3390_biomedicines11061660 crossref_primary_10_1016_j_addr_2021_113853 crossref_primary_10_1016_j_porgcoat_2020_106012 crossref_primary_10_1016_j_ejpb_2020_04_022 crossref_primary_10_1016_j_ejps_2019_04_013 crossref_primary_10_1208_s12249_018_1159_0 crossref_primary_10_1016_j_xphs_2021_10_010 crossref_primary_10_1039_D3LC00296A crossref_primary_10_1208_s12249_018_1260_4 crossref_primary_10_1124_dmd_118_080424 crossref_primary_10_3390_pharmaceutics15112584 crossref_primary_10_1016_j_ejpb_2018_12_010 crossref_primary_10_1016_j_fm_2020_103671 crossref_primary_10_1016_j_ejpb_2019_01_026 crossref_primary_10_3390_pharmaceutics15041069 crossref_primary_10_1016_j_colsurfb_2020_111339 crossref_primary_10_1093_femsre_fuad022 crossref_primary_10_3390_pharmaceutics15102397 crossref_primary_10_3390_pharmaceutics14051049 crossref_primary_10_1016_j_addr_2021_02_001 crossref_primary_10_1016_j_foodres_2021_110743 crossref_primary_10_1007_s11095_023_03597_8 crossref_primary_10_1016_j_ejps_2017_06_037 crossref_primary_10_1016_j_ejps_2019_04_003 crossref_primary_10_1016_j_addr_2016_03_009 crossref_primary_10_3390_pharmaceutics16081040 crossref_primary_10_1208_s12249_021_02038_2 crossref_primary_10_1208_s12249_018_1022_3 crossref_primary_10_3390_pharmaceutics15112592 crossref_primary_10_3390_pharmaceutics15061740 crossref_primary_10_1016_j_jconrel_2021_08_026 crossref_primary_10_3390_pharmaceutics14020291 crossref_primary_10_1002_mnfr_202000334 crossref_primary_10_1038_s41596_018_0119_1 crossref_primary_10_1016_j_ejps_2021_106018 crossref_primary_10_1016_j_ejps_2024_106853 crossref_primary_10_3390_pharmaceutics13081274 crossref_primary_10_1186_s41120_022_00063_4 crossref_primary_10_1007_s11095_021_03124_7 crossref_primary_10_1021_acs_molpharmaceut_0c00903 crossref_primary_10_1016_j_ejpb_2016_09_009 crossref_primary_10_1208_s12249_022_02256_2 crossref_primary_10_1002_cpt_3313 crossref_primary_10_1248_bpb_b24_00566 crossref_primary_10_1016_j_ejps_2019_105060 crossref_primary_10_1016_j_ijpharm_2021_121329 crossref_primary_10_1016_j_ejpb_2020_02_002 crossref_primary_10_1016_j_ejpb_2024_114313 crossref_primary_10_1093_jpp_rgaa055 crossref_primary_10_1016_j_jconrel_2024_04_016 crossref_primary_10_3390_pharmaceutics16030351 crossref_primary_10_1016_j_ijpharm_2017_08_126 crossref_primary_10_1208_s12249_022_02494_4 crossref_primary_10_1080_17425255_2021_1951223 crossref_primary_10_1016_j_drudis_2020_06_012 crossref_primary_10_1016_j_drudis_2020_06_011 crossref_primary_10_1038_s41928_024_01160_w crossref_primary_10_1016_j_ejps_2023_106452 crossref_primary_10_1016_j_xphs_2019_09_025 crossref_primary_10_29219_fnr_v65_5570 crossref_primary_10_1016_j_ejps_2024_106911 crossref_primary_10_1016_j_addr_2023_114906 crossref_primary_10_1111_jphp_12999 crossref_primary_10_1016_j_ejpb_2019_07_011 crossref_primary_10_1016_j_ijpharm_2016_11_063 crossref_primary_10_1021_acs_molpharmaceut_1c00778 crossref_primary_10_1016_j_ejps_2020_105535 crossref_primary_10_1016_j_xphs_2020_11_021 crossref_primary_10_1021_acs_molpharmaceut_7b00763 crossref_primary_10_1016_j_ctrv_2021_102281 crossref_primary_10_1007_s11095_017_2113_7 crossref_primary_10_1016_j_ejpb_2020_03_013 crossref_primary_10_3390_pharmaceutics14040801 crossref_primary_10_1016_j_ejpb_2016_10_027 crossref_primary_10_1016_j_ejpb_2018_03_011 crossref_primary_10_1016_j_ejps_2021_105812 crossref_primary_10_1016_j_xphs_2020_10_066 crossref_primary_10_1021_acs_molpharmaceut_6b00497 crossref_primary_10_3390_pharmaceutics11080416 crossref_primary_10_1016_j_ijpharm_2022_122499 crossref_primary_10_1016_j_xphs_2024_01_001 crossref_primary_10_1016_j_xphs_2021_04_007 crossref_primary_10_1016_j_microc_2024_112132 crossref_primary_10_1016_j_ejps_2019_01_012 crossref_primary_10_1016_j_jddst_2019_101338 crossref_primary_10_1111_1541_4337_70034 crossref_primary_10_1016_j_ejps_2024_106814 crossref_primary_10_1021_acs_molpharmaceut_1c00792 crossref_primary_10_1016_j_jconrel_2019_10_023 crossref_primary_10_1208_s12248_022_00690_5 crossref_primary_10_1016_j_ijpharm_2018_04_005 crossref_primary_10_1007_s11095_017_2289_x crossref_primary_10_1111_lam_13683 crossref_primary_10_3389_fnut_2022_974771 crossref_primary_10_3390_jcm12165272 crossref_primary_10_1016_j_ejpb_2024_114341 crossref_primary_10_1016_j_jconrel_2023_04_047 crossref_primary_10_1016_j_ijpx_2023_100177 crossref_primary_10_1016_j_ejps_2020_105517 crossref_primary_10_1016_j_ijpharm_2022_122069 crossref_primary_10_1016_j_ejps_2019_105031 crossref_primary_10_1021_acs_molpharmaceut_4c00117 crossref_primary_10_1039_D3FO00796K crossref_primary_10_1021_acs_molpharmaceut_7b00623 crossref_primary_10_1016_j_xphs_2023_02_009 crossref_primary_10_1016_j_addr_2021_114084 crossref_primary_10_1016_j_ejps_2021_106100 crossref_primary_10_1016_j_ejps_2016_08_060 crossref_primary_10_1016_j_ejps_2021_105750 crossref_primary_10_1208_s12249_020_01662_8 crossref_primary_10_1016_j_ejps_2024_106788 crossref_primary_10_1021_acs_molpharmaceut_6b00877 crossref_primary_10_3390_pharmaceutics15112576 crossref_primary_10_1208_s12248_024_00912_y crossref_primary_10_1016_j_ejpb_2020_08_025 crossref_primary_10_1111_1541_4337_12749 crossref_primary_10_1002_cpdd_1237 crossref_primary_10_1016_j_livsci_2017_06_011 crossref_primary_10_1208_s12248_021_00590_0 crossref_primary_10_1124_pharmrev_123_001159 crossref_primary_10_1021_acs_molpharmaceut_9b00799 crossref_primary_10_1208_s12248_021_00601_0 crossref_primary_10_1021_acs_molpharmaceut_4c01038 crossref_primary_10_1016_j_ejps_2020_105627 crossref_primary_10_3390_molecules25194479 crossref_primary_10_3389_fmicb_2022_828359 crossref_primary_10_1002_cpdd_924 |
Cites_doi | 10.1016/S0169-409X(00)00130-7 10.1211/0022357023367 10.1021/js960085v 10.1108/02602281311324681 10.1007/BF01300748 10.1016/j.ijpharm.2013.04.034 10.1016/j.jconrel.2005.08.018 10.1016/j.gie.2013.03.170 10.2165/00003088-199936030-00004 10.1002/jps.24274 10.1016/j.ejps.2013.09.018 10.1007/BF01324736 10.1007/s11095-007-9236-1 10.1007/s10620-005-3048-0 10.1021/mp300607e 10.1053/j.gastro.2008.05.021 10.1038/nrgastro.2012.57 10.1097/00004836-200608000-00010 10.1023/A:1015827908309 10.1038/clpt.2012.73 10.1007/s10620-009-0899-9 10.1111/j.1365-2982.2012.01916.x 10.1136/gut.30.5.573 10.1016/j.addr.2007.08.043 10.1111/j.1365-2982.2007.01061.x 10.1152/ajpgi.2001.280.6.G1227 10.1016/j.ejpb.2015.03.009 10.1088/0031-9155/60/3/1367 10.1211/jpp.59.1.0004 10.1136/gut.31.9.1003 10.1046/j.1365-2125.2003.01775.x 10.1080/003655200750023543 10.1016/j.appet.2011.03.006 10.1016/0016-5085(86)90573-1 10.1016/j.ejpb.2008.05.011 10.1007/s00228-010-0834-1 10.1021/mp500022u 10.1038/clpt.2014.87 10.1007/s11095-008-9580-9 10.1002/cpdd.45 10.1111/j.1365-2982.2006.00759.x 10.1038/ajg.2013.132 10.1016/j.ejpb.2008.05.029 10.1053/j.gastro.2006.03.023 10.1159/000142726 10.1208/s12248-008-9025-8 10.1158/1078-0432.CCR-10-0663 10.1177/1756283X12437874 10.1200/JCO.2008.18.3285 10.1021/mp300604u 10.1016/j.addr.2005.01.025 |
ContentType | Journal Article |
Copyright | 2015 Elsevier B.V. |
Copyright_xml | – notice: 2015 Elsevier B.V. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.jconrel.2015.10.022 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-4995 |
EndPage | 78 |
ExternalDocumentID | 26476174 10_1016_j_jconrel_2015_10_022 S0168365915301917 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AABXZ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AEZYN AFKWA AFRZQ AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HMT IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SDF SDG SDP SES SPC SPCBC SSM SSP SSZ T5K TEORI ~G- .GJ 29K 3O- AAHBH AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ABXDB ACLOT ACNNM ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CITATION D-I EFKBS FEDTE FGOYB G-2 HVGLF HZ~ R2- SEW SPT WUQ ~HD AGCQF AGRNS CGR CUY CVF ECM EIF NPM SSH 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c501t-c3e37567c76d36d2edc6fdbcb52b12f04abff0bcdebe418032d710fec995c96d3 |
IEDL.DBID | .~1 |
ISSN | 0168-3659 1873-4995 |
IngestDate | Mon Sep 29 06:30:50 EDT 2025 Tue Sep 30 23:08:32 EDT 2025 Mon Jul 21 05:55:14 EDT 2025 Thu Apr 24 23:06:21 EDT 2025 Wed Oct 01 04:45:04 EDT 2025 Fri Feb 23 02:33:28 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Pt A |
Keywords | Solid oral dosage form Food effect Transit time Fed state FDA standard breakfast Gastrointestinal pH Oral drug delivery Pressure |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c501t-c3e37567c76d36d2edc6fdbcb52b12f04abff0bcdebe418032d710fec995c96d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26476174 |
PQID | 1751194540 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2010217867 proquest_miscellaneous_1751194540 pubmed_primary_26476174 crossref_citationtrail_10_1016_j_jconrel_2015_10_022 crossref_primary_10_1016_j_jconrel_2015_10_022 elsevier_sciencedirect_doi_10_1016_j_jconrel_2015_10_022 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-12-28 |
PublicationDateYYYYMMDD | 2015-12-28 |
PublicationDate_xml | – month: 12 year: 2015 text: 2015-12-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of controlled release |
PublicationTitleAlternate | J Control Release |
PublicationYear | 2015 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Schubert, Peura (bb0195) 2008; 134 Tran, Brun, Kuo (bb0115) 2012; 5 Khanna (bb0275) 2013; 33 Zhang, Wu, Lee, Zhao (bb0230) 2014; 96 FDA (bb0015) 2002 Custodio, Wu, Benet (bb0025) 2008; 60 Koch, Im, Kim, Urruticoechea Ribate, Stephenson, Botbyl, Cartee, Holshouser, Ridgway (bb0240) 2013; 2 Dressman, Berardi, Dermentzoglou, Russell, Schmaltz, Barnett, Jarvenpaa (bb0080) 1990; 7 Kang, Ratain (bb0010) 2010; 16 Simonian, Vo, Doma, Fisher, Parkman (bb0100) 2005; 50 Marciani, Gowland, Spiller, Manoj, Moore, Young, Fillery-Travis (bb0200) 2001; 280 Markopoulos, Andreas, Vertzoni, Dressman, Reppas (bb0250) 2015; 93 Kellow, Borody, Phillips, Tucker, Haddad (bb0150) 1986; 91 Deloose, Janssen, Depoortere, Tack (bb0140) 2012; 9 Malagelada, Go, Summerskill (bb0175) 1979; 24 Weitschies, Kosch, Mönnikes, Trahms (bb0260) 2005; 57 van der Schaar, Dijksman, Broekhuizen-de Gast, Shimizu, van Lelyveld, Zou, Iordanov, Wanke, Siersema (bb0095) 2013; 78 Koziolek, Garbacz, Neumann, Weitschies (bb0045) 2013; 10 Cassilly, Kantor, Knight, Maurer, Fisher, Semler, Parkman (bb0090) 2008; 20 Madsen, Dahl (bb0145) 1990; 31 McLauchlan, Fullarton, Crean, McColl (bb0210) 1989; 30 Schulze (bb0120) 2006; 18 Koziolek, Garbacz, Neumann, Weitschies (bb0065) 2013; 10 Ibekwe, Fadda, McConnell, Khela, Evans, Basit (bb0105) 2008; 25 Koziolek, Grimm, Becker, Iordanov, Zou, Shimizu, Wanke, Garbacz, Weitschies (bb0130) 2015; 104 Gu, Li, Levons, Lentz, Gandhi, Raghavan, Smith (bb0035) 2007; 24 Maqbool, Parkman, Friedenberg (bb0110) 2009; 54 Abbas, Wilding, Sitrin (bb0125) 2014; 3 Willis, Thomas, Willis, Slavin (bb0160) 2011; 57 J.R. Semler, Method of locating an ingested capsule, U.S. patent 2012/0209083 A1, August 16, 2012. Lentz (bb0040) 2008; 10 Varum, Hatton, Basit (bb0070) 2013; 457 Budha, Frymoyer, Smelick, Jin, Yago, Dresser, Holden, Benet, Ware (bb0235) 2012; 92 Garbacz, Wedemeyer, Nagel, Giessmann, Mönnikes, Wilson, Siegmund, Weitschies (bb0255) 2008; 70 Koch, Reddy, Cohen, Lewis, Whitehead, Mackay, Stead, Beelen, Lewis (bb0245) 2009; 27 Kahrilas, McColl, Fox, O'Rourke, Sifrim, Smout, Boeckxstaens (bb0215) 2013; 108 Saruwatari, Yasui-Furukori, Inoue, Kaneko (bb0060) 2010; 66 Ewe, Press, Bollen, Schuhn (bb0155) 1991; 36 Klein, Butler, Hempenstall, Reppas, Dressman (bb0170) 2004; 56 Weitschies, Friedrich, Wedemeyer, Schmidtmann, Kosch, Kinzig, Trahms, Sorgel, Siegmund, Horkovics-Kovats, Schwarz, Raneburger, Mönnikes (bb0220) 2008; 70 Weitschies, Wedemeyer, Kosch, Fach, Nagel, Söderlind, Trahms, Abrahamsson, Mönnikes (bb0265) 2005; 108 Podczeck, Course, Newton, Short (bb0165) 2007; 59 Yasui-Furukori, Takahata, Kondo, Mihara, Kaneko, Tateishi (bb0055) 2003; 55 Pohl, Fox, Fried, Göke, Prinz, Mönnikes, Rogler, Dauer, Keller, Lippl, Schiefke, Seidler, Allescher (bb0190) 2008; 77 Hila, Bouali, Xue, Knuff, Castell (bb0205) 2006; 40 Fleisher, Li, Zhou, Pao, Karim (bb0005) 1999; 36 Camilleri (bb0135) 2006; 131 Zane, Guo, MacGerorge, Vicat, Ollier (bb0030) 2014; 57 Hoad, Parker, Hudders, Costigan, Cox (bb0185) 2015; 60 Charman, Porter, Mithani, Dressman (bb0085) 1997; 86 Castedal, Björnsson, Gretarsdottir, Fjälling, Abrahamsson (bb0225) 2000; 35 EMA (bb0020) 2012 Koziolek, Grimm, Garbacz, Kühn, Weitschies (bb0050) 2014; 11 Sauter, Curcic, Menne, Goetze, Fried, Schwizer, Steingoetter (bb0180) 2012; 24 Hörter, Dressman (bb0075) 2001; 46 Cassilly (10.1016/j.jconrel.2015.10.022_bb0090) 2008; 20 Weitschies (10.1016/j.jconrel.2015.10.022_bb0260) 2005; 57 Camilleri (10.1016/j.jconrel.2015.10.022_bb0135) 2006; 131 Simonian (10.1016/j.jconrel.2015.10.022_bb0100) 2005; 50 Castedal (10.1016/j.jconrel.2015.10.022_bb0225) 2000; 35 Budha (10.1016/j.jconrel.2015.10.022_bb0235) 2012; 92 Kellow (10.1016/j.jconrel.2015.10.022_bb0150) 1986; 91 Ibekwe (10.1016/j.jconrel.2015.10.022_bb0105) 2008; 25 Tran (10.1016/j.jconrel.2015.10.022_bb0115) 2012; 5 Klein (10.1016/j.jconrel.2015.10.022_bb0170) 2004; 56 10.1016/j.jconrel.2015.10.022_bb0270 Hörter (10.1016/j.jconrel.2015.10.022_bb0075) 2001; 46 Markopoulos (10.1016/j.jconrel.2015.10.022_bb0250) 2015; 93 Hila (10.1016/j.jconrel.2015.10.022_bb0205) 2006; 40 Saruwatari (10.1016/j.jconrel.2015.10.022_bb0060) 2010; 66 Willis (10.1016/j.jconrel.2015.10.022_bb0160) 2011; 57 Fleisher (10.1016/j.jconrel.2015.10.022_bb0005) 1999; 36 Zane (10.1016/j.jconrel.2015.10.022_bb0030) 2014; 57 Weitschies (10.1016/j.jconrel.2015.10.022_bb0265) 2005; 108 Garbacz (10.1016/j.jconrel.2015.10.022_bb0255) 2008; 70 Koziolek (10.1016/j.jconrel.2015.10.022_bb0045) 2013; 10 Schulze (10.1016/j.jconrel.2015.10.022_bb0120) 2006; 18 Zhang (10.1016/j.jconrel.2015.10.022_bb0230) 2014; 96 Madsen (10.1016/j.jconrel.2015.10.022_bb0145) 1990; 31 Varum (10.1016/j.jconrel.2015.10.022_bb0070) 2013; 457 Maqbool (10.1016/j.jconrel.2015.10.022_bb0110) 2009; 54 Deloose (10.1016/j.jconrel.2015.10.022_bb0140) 2012; 9 Koziolek (10.1016/j.jconrel.2015.10.022_bb0050) 2014; 11 Kahrilas (10.1016/j.jconrel.2015.10.022_bb0215) 2013; 108 Pohl (10.1016/j.jconrel.2015.10.022_bb0190) 2008; 77 Custodio (10.1016/j.jconrel.2015.10.022_bb0025) 2008; 60 Yasui-Furukori (10.1016/j.jconrel.2015.10.022_bb0055) 2003; 55 Schubert (10.1016/j.jconrel.2015.10.022_bb0195) 2008; 134 Malagelada (10.1016/j.jconrel.2015.10.022_bb0175) 1979; 24 FDA (10.1016/j.jconrel.2015.10.022_bb0015) 2002 Lentz (10.1016/j.jconrel.2015.10.022_bb0040) 2008; 10 Weitschies (10.1016/j.jconrel.2015.10.022_bb0220) 2008; 70 Kang (10.1016/j.jconrel.2015.10.022_bb0010) 2010; 16 Hoad (10.1016/j.jconrel.2015.10.022_bb0185) 2015; 60 Koziolek (10.1016/j.jconrel.2015.10.022_bb0065) 2013; 10 Marciani (10.1016/j.jconrel.2015.10.022_bb0200) 2001; 280 van der Schaar (10.1016/j.jconrel.2015.10.022_bb0095) 2013; 78 Koch (10.1016/j.jconrel.2015.10.022_bb0240) 2013; 2 Charman (10.1016/j.jconrel.2015.10.022_bb0085) 1997; 86 Sauter (10.1016/j.jconrel.2015.10.022_bb0180) 2012; 24 Dressman (10.1016/j.jconrel.2015.10.022_bb0080) 1990; 7 Podczeck (10.1016/j.jconrel.2015.10.022_bb0165) 2007; 59 Gu (10.1016/j.jconrel.2015.10.022_bb0035) 2007; 24 Ewe (10.1016/j.jconrel.2015.10.022_bb0155) 1991; 36 Khanna (10.1016/j.jconrel.2015.10.022_bb0275) 2013; 33 Koch (10.1016/j.jconrel.2015.10.022_bb0245) 2009; 27 EMA (10.1016/j.jconrel.2015.10.022_bb0020) 2012 Koziolek (10.1016/j.jconrel.2015.10.022_bb0130) 2015; 104 McLauchlan (10.1016/j.jconrel.2015.10.022_bb0210) 1989; 30 Abbas (10.1016/j.jconrel.2015.10.022_bb0125) 2014; 3 |
References_xml | – volume: 96 start-page: 266 year: 2014 end-page: 277 ident: bb0230 article-title: pH-dependent drug–drug interactions for weak base drugs: potential implications for new drug development publication-title: Clin. Pharmacol. Ther. – volume: 10 start-page: 2211 year: 2013 end-page: 2221 ident: bb0045 article-title: Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution publication-title: Mol. Pharm. – volume: 5 start-page: 249 year: 2012 end-page: 260 ident: bb0115 article-title: Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice publication-title: Ther. Adv. Gastroenterol. – volume: 91 start-page: 386 year: 1986 end-page: 395 ident: bb0150 article-title: Human interdigestive motility: variations in patterns from esophagus to colon publication-title: Gastroenterology – volume: 3 start-page: 1103 year: 2014 end-page: 1107 ident: bb0125 article-title: Does colonic transit time affect colonic pH publication-title: J. Gastroenterol. Hepatol. Res. – volume: 104 start-page: 2855 year: 2015 end-page: 2863 ident: bb0130 article-title: Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap® system publication-title: J. Pharm. Sci. – volume: 92 start-page: 203 year: 2012 end-page: 213 ident: bb0235 article-title: Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy? publication-title: Clin. Pharmacol. Ther. – volume: 2 start-page: 336 year: 2013 end-page: 341 ident: bb0240 article-title: Effects of esomeprazole on the pharmacokinetics of lapatinib in breast cancer patients publication-title: Clin. Pharm. Drug Dev. – volume: 10 start-page: 282 year: 2008 end-page: 288 ident: bb0040 article-title: Current methods for predicting human food effect publication-title: AAPS J. – volume: 280 start-page: G1227 year: 2001 end-page: G1233 ident: bb0200 article-title: Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 50 start-page: 2276 year: 2005 end-page: 2285 ident: bb0100 article-title: Regional postprandial differences in pH within the stomach and gastroesophageal junction publication-title: Dig. Dis. Sci. – volume: 36 start-page: 233 year: 1999 end-page: 254 ident: bb0005 article-title: Drug, meal and formulation interactions influencing drug absorption after oral administration: clinical implications publication-title: Clin. Pharmacokinet. – volume: 11 start-page: 1632 year: 2014 end-page: 1639 ident: bb0050 article-title: Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI publication-title: Mol. Pharm. – volume: 27 start-page: 1191 year: 2009 end-page: 1196 ident: bb0245 article-title: Effects of food on the relative bioavailability of lapatinib in cancer patients publication-title: J. Clin. Oncol. – volume: 31 start-page: 1003 year: 1990 end-page: 1005 ident: bb0145 article-title: Human migrating myoelectric complex in relation to gastrointestinal transit of a meal publication-title: Gut – volume: 55 start-page: 382 year: 2003 end-page: 388 ident: bb0055 article-title: Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam publication-title: Br. J. Clin. Pharmacol. – volume: 134 start-page: 1842 year: 2008 end-page: 1860 ident: bb0195 article-title: Control of gastric acid secretion in health and disease publication-title: Gastroenterology – volume: 93 start-page: 173 year: 2015 end-page: 182 ident: bb0250 article-title: In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media publication-title: Eur. J. Pharm. Biopharm. – volume: 57 start-page: 207 year: 2014 end-page: 213 ident: bb0030 article-title: Use of the pentagastrin dog model to explore the food effects on formulations in early drug development publication-title: Eur. J. Pharm. Sci. – volume: 60 start-page: 717 year: 2008 end-page: 733 ident: bb0025 article-title: Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption publication-title: Adv. Drug Deliv. Rev. – volume: 54 start-page: 2167 year: 2009 end-page: 2174 ident: bb0110 article-title: Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit publication-title: Dig. Dis. Sci. – volume: 7 start-page: 756 year: 1990 end-page: 761 ident: bb0080 article-title: Upper gastrointestinal (GI) pH in young, healthy men and women publication-title: Pharm. Res. – volume: 40 start-page: 612 year: 2006 end-page: 617 ident: bb0205 article-title: Postprandial stomach contents have multiple acid layers publication-title: J. Clin. Gastroenterol. – reference: J.R. Semler, Method of locating an ingested capsule, U.S. patent 2012/0209083 A1, August 16, 2012. – volume: 131 start-page: 640 year: 2006 end-page: 658 ident: bb0135 article-title: Integrated upper gastrointestinal response to food intake publication-title: Gastroenterology – volume: 18 start-page: 172 year: 2006 end-page: 183 ident: bb0120 article-title: Imaging and modelling of digestion in the stomach and the duodenum publication-title: Neurogastroenterol. Motil. – volume: 57 start-page: 38 year: 2011 end-page: 44 ident: bb0160 article-title: Feasibility of measuring gastric emptying time, with a wireless motility device, after subjects consume fiber-matched liquid and solid breakfasts publication-title: Appetite – volume: 70 start-page: 421 year: 2008 end-page: 428 ident: bb0255 article-title: Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses publication-title: Eur. J. Pharm. Biopharm. – volume: 9 start-page: 271 year: 2012 end-page: 285 ident: bb0140 article-title: The migrating motor complex: control mechanisms and its role in health and disease publication-title: Nat. Rev. Gastroenterol. Hepatol. – year: 2002 ident: bb0015 article-title: Guidance for Industry: food-effect bioavailability and fed bioequivalence studies – volume: 24 start-page: 1118 year: 2007 end-page: 1130 ident: bb0035 article-title: Predicting effect of food on extent of drug absorption based on physicochemical properties publication-title: Pharm. Res. – volume: 60 start-page: 1367 year: 2015 end-page: 1383 ident: bb0185 article-title: Measurement of gastric meal and secretion volumes using magnetic resonance imaging publication-title: Phys. Med. Biol. – volume: 77 start-page: 184 year: 2008 end-page: 197 ident: bb0190 article-title: Do we need gastric acid? publication-title: Digestion – volume: 46 start-page: 75 year: 2001 end-page: 87 ident: bb0075 article-title: Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract publication-title: Adv. Drug Deliv. Rev. – volume: 30 start-page: 573 year: 1989 end-page: 578 ident: bb0210 article-title: Comparison of gastric body and antral pH: a 24 publication-title: Gut – volume: 108 start-page: 375 year: 2005 end-page: 385 ident: bb0265 article-title: Impact of the intragastric location of extended release tablets on food interactions publication-title: J. Control. Release – volume: 78 start-page: 520 year: 2013 end-page: 528 ident: bb0095 article-title: A novel ingestible electronic drug delivery and monitoring device publication-title: Gastrointest. Endosc. – volume: 70 start-page: 641 year: 2008 end-page: 648 ident: bb0220 article-title: Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying publication-title: Eur. J. Pharm. Biopharm. – volume: 57 start-page: 1210 year: 2005 end-page: 1222 ident: bb0260 article-title: Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms publication-title: Adv. Drug Deliv. Rev. – volume: 108 start-page: 1058 year: 2013 end-page: 1064 ident: bb0215 article-title: The acid pocket: a target for treatment in reflux disease? publication-title: Am. J. Gastroenterol. – volume: 457 start-page: 446 year: 2013 end-page: 460 ident: bb0070 article-title: Food, physiology and drug delivery publication-title: Int. J. Pharm. – volume: 59 start-page: 23 year: 2007 end-page: 27 ident: bb0165 article-title: The influence of non-disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers publication-title: J. Pharm. Pharmacol. – volume: 33 start-page: 228 year: 2013 end-page: 237 ident: bb0275 article-title: Remedial and adaptive solutions of ISFET non-ideal behavior publication-title: Sens. Rev. – volume: 16 start-page: 4446 year: 2010 end-page: 4451 ident: bb0010 article-title: Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products publication-title: Clin. Cancer Res. – volume: 10 start-page: 1610 year: 2013 end-page: 1622 ident: bb0065 article-title: Simulating the postprandial stomach: physiological considerations for dissolution and release testing publication-title: Mol. Pharm. – volume: 24 start-page: 101 year: 1979 end-page: 110 ident: bb0175 article-title: Different gastric, pancreatic, and biliary responses to solid–liquid or homogenized meals publication-title: Dig. Dis. Sci. – volume: 86 start-page: 269 year: 1997 end-page: 282 ident: bb0085 article-title: Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH publication-title: J. Pharm. Sci. – volume: 24 start-page: 632-e273 year: 2012 ident: bb0180 article-title: Measuring the interaction of meal and gastric secretion: a combined quantitative magnetic resonance imaging and pharmacokinetic modeling approach publication-title: Neurogastroenterol. Motil. – volume: 36 start-page: 146 year: 1991 end-page: 152 ident: bb0155 article-title: Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector publication-title: Dig. Dis. Sci. – volume: 66 start-page: 899 year: 2010 end-page: 902 ident: bb0060 article-title: Effect of dose timing in relation to food intake on systemic exposure to blonanserin publication-title: Eur. J. Clin. Pharmacol. – volume: 35 start-page: 590 year: 2000 end-page: 598 ident: bb0225 article-title: Scintigraphic assessment of interdigestive duodenogastric reflux in humans: distinguishing between duodenal and biliary reflux material publication-title: Scand. J. Gastroenterol. – volume: 20 start-page: 311 year: 2008 end-page: 319 ident: bb0090 article-title: Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy publication-title: Neurogastroenterol. Motil. – volume: 56 start-page: 605 year: 2004 end-page: 610 ident: bb0170 article-title: Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts publication-title: J. Pharm. Pharmacol. – year: 2012 ident: bb0020 article-title: Guideline on the investigation of drug interactions publication-title: Committee for Human Medicinal Products (CHMP) – volume: 25 start-page: 1828 year: 2008 end-page: 1835 ident: bb0105 article-title: Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems publication-title: Pharm. Res. – volume: 46 start-page: 75 year: 2001 ident: 10.1016/j.jconrel.2015.10.022_bb0075 article-title: Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(00)00130-7 – volume: 56 start-page: 605 year: 2004 ident: 10.1016/j.jconrel.2015.10.022_bb0170 article-title: Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts publication-title: J. Pharm. Pharmacol. doi: 10.1211/0022357023367 – volume: 86 start-page: 269 year: 1997 ident: 10.1016/j.jconrel.2015.10.022_bb0085 article-title: Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH publication-title: J. Pharm. Sci. doi: 10.1021/js960085v – volume: 33 start-page: 228 year: 2013 ident: 10.1016/j.jconrel.2015.10.022_bb0275 article-title: Remedial and adaptive solutions of ISFET non-ideal behavior publication-title: Sens. Rev. doi: 10.1108/02602281311324681 – volume: 36 start-page: 146 year: 1991 ident: 10.1016/j.jconrel.2015.10.022_bb0155 article-title: Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector publication-title: Dig. Dis. Sci. doi: 10.1007/BF01300748 – volume: 457 start-page: 446 year: 2013 ident: 10.1016/j.jconrel.2015.10.022_bb0070 article-title: Food, physiology and drug delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.04.034 – volume: 108 start-page: 375 year: 2005 ident: 10.1016/j.jconrel.2015.10.022_bb0265 article-title: Impact of the intragastric location of extended release tablets on food interactions publication-title: J. Control. Release doi: 10.1016/j.jconrel.2005.08.018 – volume: 78 start-page: 520 year: 2013 ident: 10.1016/j.jconrel.2015.10.022_bb0095 article-title: A novel ingestible electronic drug delivery and monitoring device publication-title: Gastrointest. Endosc. doi: 10.1016/j.gie.2013.03.170 – volume: 36 start-page: 233 year: 1999 ident: 10.1016/j.jconrel.2015.10.022_bb0005 article-title: Drug, meal and formulation interactions influencing drug absorption after oral administration: clinical implications publication-title: Clin. Pharmacokinet. doi: 10.2165/00003088-199936030-00004 – volume: 104 start-page: 2855 year: 2015 ident: 10.1016/j.jconrel.2015.10.022_bb0130 article-title: Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap® system publication-title: J. Pharm. Sci. doi: 10.1002/jps.24274 – volume: 57 start-page: 207 year: 2014 ident: 10.1016/j.jconrel.2015.10.022_bb0030 article-title: Use of the pentagastrin dog model to explore the food effects on formulations in early drug development publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2013.09.018 – volume: 24 start-page: 101 year: 1979 ident: 10.1016/j.jconrel.2015.10.022_bb0175 article-title: Different gastric, pancreatic, and biliary responses to solid–liquid or homogenized meals publication-title: Dig. Dis. Sci. doi: 10.1007/BF01324736 – volume: 24 start-page: 1118 year: 2007 ident: 10.1016/j.jconrel.2015.10.022_bb0035 article-title: Predicting effect of food on extent of drug absorption based on physicochemical properties publication-title: Pharm. Res. doi: 10.1007/s11095-007-9236-1 – volume: 50 start-page: 2276 year: 2005 ident: 10.1016/j.jconrel.2015.10.022_bb0100 article-title: Regional postprandial differences in pH within the stomach and gastroesophageal junction publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-005-3048-0 – volume: 10 start-page: 2211 year: 2013 ident: 10.1016/j.jconrel.2015.10.022_bb0045 article-title: Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution publication-title: Mol. Pharm. doi: 10.1021/mp300607e – volume: 134 start-page: 1842 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0195 article-title: Control of gastric acid secretion in health and disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.05.021 – volume: 9 start-page: 271 year: 2012 ident: 10.1016/j.jconrel.2015.10.022_bb0140 article-title: The migrating motor complex: control mechanisms and its role in health and disease publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/nrgastro.2012.57 – volume: 40 start-page: 612 year: 2006 ident: 10.1016/j.jconrel.2015.10.022_bb0205 article-title: Postprandial stomach contents have multiple acid layers publication-title: J. Clin. Gastroenterol. doi: 10.1097/00004836-200608000-00010 – volume: 7 start-page: 756 year: 1990 ident: 10.1016/j.jconrel.2015.10.022_bb0080 article-title: Upper gastrointestinal (GI) pH in young, healthy men and women publication-title: Pharm. Res. doi: 10.1023/A:1015827908309 – volume: 92 start-page: 203 year: 2012 ident: 10.1016/j.jconrel.2015.10.022_bb0235 article-title: Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy? publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2012.73 – volume: 54 start-page: 2167 year: 2009 ident: 10.1016/j.jconrel.2015.10.022_bb0110 article-title: Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-009-0899-9 – volume: 24 start-page: 632-e273 year: 2012 ident: 10.1016/j.jconrel.2015.10.022_bb0180 article-title: Measuring the interaction of meal and gastric secretion: a combined quantitative magnetic resonance imaging and pharmacokinetic modeling approach publication-title: Neurogastroenterol. Motil. doi: 10.1111/j.1365-2982.2012.01916.x – volume: 30 start-page: 573 year: 1989 ident: 10.1016/j.jconrel.2015.10.022_bb0210 article-title: Comparison of gastric body and antral pH: a 24hour ambulatory study in healthy volunteers publication-title: Gut doi: 10.1136/gut.30.5.573 – volume: 60 start-page: 717 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0025 article-title: Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2007.08.043 – volume: 20 start-page: 311 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0090 article-title: Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy publication-title: Neurogastroenterol. Motil. doi: 10.1111/j.1365-2982.2007.01061.x – year: 2002 ident: 10.1016/j.jconrel.2015.10.022_bb0015 – volume: 280 start-page: G1227 year: 2001 ident: 10.1016/j.jconrel.2015.10.022_bb0200 article-title: Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.2001.280.6.G1227 – volume: 93 start-page: 173 year: 2015 ident: 10.1016/j.jconrel.2015.10.022_bb0250 article-title: In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2015.03.009 – volume: 60 start-page: 1367 year: 2015 ident: 10.1016/j.jconrel.2015.10.022_bb0185 article-title: Measurement of gastric meal and secretion volumes using magnetic resonance imaging publication-title: Phys. Med. Biol. doi: 10.1088/0031-9155/60/3/1367 – volume: 59 start-page: 23 year: 2007 ident: 10.1016/j.jconrel.2015.10.022_bb0165 article-title: The influence of non-disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers publication-title: J. Pharm. Pharmacol. doi: 10.1211/jpp.59.1.0004 – volume: 31 start-page: 1003 year: 1990 ident: 10.1016/j.jconrel.2015.10.022_bb0145 article-title: Human migrating myoelectric complex in relation to gastrointestinal transit of a meal publication-title: Gut doi: 10.1136/gut.31.9.1003 – volume: 55 start-page: 382 year: 2003 ident: 10.1016/j.jconrel.2015.10.022_bb0055 article-title: Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam publication-title: Br. J. Clin. Pharmacol. doi: 10.1046/j.1365-2125.2003.01775.x – volume: 35 start-page: 590 year: 2000 ident: 10.1016/j.jconrel.2015.10.022_bb0225 article-title: Scintigraphic assessment of interdigestive duodenogastric reflux in humans: distinguishing between duodenal and biliary reflux material publication-title: Scand. J. Gastroenterol. doi: 10.1080/003655200750023543 – volume: 57 start-page: 38 year: 2011 ident: 10.1016/j.jconrel.2015.10.022_bb0160 article-title: Feasibility of measuring gastric emptying time, with a wireless motility device, after subjects consume fiber-matched liquid and solid breakfasts publication-title: Appetite doi: 10.1016/j.appet.2011.03.006 – volume: 91 start-page: 386 year: 1986 ident: 10.1016/j.jconrel.2015.10.022_bb0150 article-title: Human interdigestive motility: variations in patterns from esophagus to colon publication-title: Gastroenterology doi: 10.1016/0016-5085(86)90573-1 – volume: 70 start-page: 641 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0220 article-title: Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2008.05.011 – volume: 66 start-page: 899 year: 2010 ident: 10.1016/j.jconrel.2015.10.022_bb0060 article-title: Effect of dose timing in relation to food intake on systemic exposure to blonanserin publication-title: Eur. J. Clin. Pharmacol. doi: 10.1007/s00228-010-0834-1 – volume: 11 start-page: 1632 year: 2014 ident: 10.1016/j.jconrel.2015.10.022_bb0050 article-title: Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI publication-title: Mol. Pharm. doi: 10.1021/mp500022u – volume: 96 start-page: 266 year: 2014 ident: 10.1016/j.jconrel.2015.10.022_bb0230 article-title: pH-dependent drug–drug interactions for weak base drugs: potential implications for new drug development publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2014.87 – ident: 10.1016/j.jconrel.2015.10.022_bb0270 – volume: 25 start-page: 1828 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0105 article-title: Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems publication-title: Pharm. Res. doi: 10.1007/s11095-008-9580-9 – volume: 2 start-page: 336 year: 2013 ident: 10.1016/j.jconrel.2015.10.022_bb0240 article-title: Effects of esomeprazole on the pharmacokinetics of lapatinib in breast cancer patients publication-title: Clin. Pharm. Drug Dev. doi: 10.1002/cpdd.45 – year: 2012 ident: 10.1016/j.jconrel.2015.10.022_bb0020 article-title: Guideline on the investigation of drug interactions – volume: 18 start-page: 172 year: 2006 ident: 10.1016/j.jconrel.2015.10.022_bb0120 article-title: Imaging and modelling of digestion in the stomach and the duodenum publication-title: Neurogastroenterol. Motil. doi: 10.1111/j.1365-2982.2006.00759.x – volume: 108 start-page: 1058 year: 2013 ident: 10.1016/j.jconrel.2015.10.022_bb0215 article-title: The acid pocket: a target for treatment in reflux disease? publication-title: Am. J. Gastroenterol. doi: 10.1038/ajg.2013.132 – volume: 70 start-page: 421 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0255 article-title: Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2008.05.029 – volume: 131 start-page: 640 year: 2006 ident: 10.1016/j.jconrel.2015.10.022_bb0135 article-title: Integrated upper gastrointestinal response to food intake publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.03.023 – volume: 77 start-page: 184 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0190 article-title: Do we need gastric acid? publication-title: Digestion doi: 10.1159/000142726 – volume: 10 start-page: 282 year: 2008 ident: 10.1016/j.jconrel.2015.10.022_bb0040 article-title: Current methods for predicting human food effect publication-title: AAPS J. doi: 10.1208/s12248-008-9025-8 – volume: 16 start-page: 4446 year: 2010 ident: 10.1016/j.jconrel.2015.10.022_bb0010 article-title: Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-0663 – volume: 3 start-page: 1103 year: 2014 ident: 10.1016/j.jconrel.2015.10.022_bb0125 article-title: Does colonic transit time affect colonic pH? publication-title: J. Gastroenterol. Hepatol. Res. – volume: 5 start-page: 249 year: 2012 ident: 10.1016/j.jconrel.2015.10.022_bb0115 article-title: Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice publication-title: Ther. Adv. Gastroenterol. doi: 10.1177/1756283X12437874 – volume: 27 start-page: 1191 year: 2009 ident: 10.1016/j.jconrel.2015.10.022_bb0245 article-title: Effects of food on the relative bioavailability of lapatinib in cancer patients publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2008.18.3285 – volume: 10 start-page: 1610 year: 2013 ident: 10.1016/j.jconrel.2015.10.022_bb0065 article-title: Simulating the postprandial stomach: physiological considerations for dissolution and release testing publication-title: Mol. Pharm. doi: 10.1021/mp300604u – volume: 57 start-page: 1210 year: 2005 ident: 10.1016/j.jconrel.2015.10.022_bb0260 article-title: Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2005.01.025 |
SSID | ssj0005347 |
Score | 2.5529766 |
Snippet | The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 71 |
SubjectTerms | Adult bioavailability Body Temperature breakfast Diet, High-Fat dietary recommendations drug formulations drugs Energy Intake FDA standard breakfast Fed state Female Food effect Gastric Acidity Determination gastric emptying Gastric Emptying - physiology Gastrointestinal pH Gastrointestinal Transit Humans ingestion liquids lunch Male Myoelectric Complex, Migrating - physiology oral administration Oral drug delivery Pressure Solid oral dosage form stomach Transit time |
Title | Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies |
URI | https://dx.doi.org/10.1016/j.jconrel.2015.10.022 https://www.ncbi.nlm.nih.gov/pubmed/26476174 https://www.proquest.com/docview/1751194540 https://www.proquest.com/docview/2010217867 |
Volume | 220 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1873-4995 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005347 issn: 0168-3659 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1873-4995 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005347 issn: 0168-3659 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Freedom Collection Journals customDbUrl: eissn: 1873-4995 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005347 issn: 0168-3659 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect (Elsevier) customDbUrl: eissn: 1873-4995 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005347 issn: 0168-3659 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1873-4995 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005347 issn: 0168-3659 databaseCode: AKRWK dateStart: 19930101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhvfRS-u72EaZQclrt-qGXjyE0bFoaAk0gN2PrUXbTepe1fcilv70zfmTbwxLowQcZjREaSfON9c0MY59sMKY00nEXac2FcJpnqTUcjRHiV6WkTyh2-NuFWlyLLzfy5oCdjrEwRKsczv7-TO9O6-HNfJjN-Wa5nH9HsGJSJTPcsxF5HRTBLhTR-ma__6J5pKIPmVaGU-9dFM98NVuhz7n1dAMRyxmRvJJkn33ahz87O3T2lD0ZACSc9GN8xg589ZwdX_YZqO-mcLULqKqncAyXu9zUdy9Ye04_c38UVK3DwmYBReWg48K2Ww9DAe8ausrhsKya4tbDOgCiRKDExhw1SklFpn0rFA38QqQJRQ1t7R0gAsZn7aCniUDdsxRfsuuzz1enCz5UXuBWRnHDbepTLZW2WrlUucQ7q4IrbSmTMk5CJIoyhKi0DpeAiE2UJg6RCn44y6TNUOYVO6zWlX_DAAFfoX0Wgk0ReQV079ADs1ZFwqJdVGrCxDjfuR3SklN1jJ_5yD9b5YOaclITvUY1TdjsXmzT5-V4SMCMysz_WWA52o6HRD-Oys9x89GNSlH5dVvniL3iOKMkhvv7JF31dG2UnrDX_cq5HzGiUY0QUrz9_8G9Y4-pRQybxLxnh8229R8QJzXlUbcRjtijk_Ovi4s_iSQTrQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5S59BeSt91n1MoOVm2tNqXjiE0yE1iAnUgNyHto9htZWNJh_z7zuoR04MJ9KCDVhqx7OzufKP9ZoaQr9opVShuAhNKGTBmZJDEWgVojBC_CsEt9bHDVwuR3rDvt_z2iJwNsTCeVtnv_d2e3u7WfcusH83ZdrWa_UCwomLBE1yzofc6HpFjxnFPHpHj0_lFutgzPWLWRU0LFXiBfSDPbD1do9u5s_4QIuJTz_Oi9JCJOgRBW1N0_ow87TEknHbdfE6ObPmCnFx3SajvJrDcx1RVEziB63166ruXpJn7_7k_c1-wQ8M2hbw00NJhm52FvoZ3BW3xcFiVdf7LwsYBAkXwuY0DVKrPKzLp7lxewx8Em5BX0FTWAIJgvDYGOqYIVB1R8RW5Of-2PEuDvvhCoHkY1YGObSy5kFoKEwtDrdHCmUIXnBYRdSHLC-fCQhucBSxSYUwNghX8cJJwnaDMazIqN6V9SwAxXy5t4pyOEXw59PDQCdNahEyjaRRiTNgw3pnuM5P7Ahm_s4GCts56NWVeTb4Z1TQm03uxbZea4yEBNSgz-2eOZWg-HhL9Mig_w_XnD1Xy0m6aKkP4FUWJz2N4-B3aFlCXSsgxedPNnPseIyCViCLZu__v3GfyOF1eXWaX88XFe_LEP_GEG6o-kFG9a-xHhE118alfFn8B1RwWWA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intragastric+pH+and+pressure+profiles+after+intake+of+the+high-caloric%2C+high-fat+meal+as+used+for+food+effect+studies&rft.jtitle=Journal+of+controlled+release&rft.au=Koziolek%2C+M.&rft.au=Schneider%2C+F.&rft.au=Grimm%2C+M.&rft.au=Mode%CE%B2%2C+Chr&rft.date=2015-12-28&rft.pub=Elsevier+B.V&rft.issn=0168-3659&rft.eissn=1873-4995&rft.volume=220&rft.spage=71&rft.epage=78&rft_id=info:doi/10.1016%2Fj.jconrel.2015.10.022&rft.externalDocID=S0168365915301917 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon |